Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
CCG-222740 markedly decreased SRF reporter gene activity and showed a greater inhibitory effect on MRTF/SRF target genes than the previously described MRTF-A inhibitor CCG-203971
Cells incubated with PF-06447475 alone (0
Pan-AKT kinase inhibitor GSK-690693 binds to and inhibits Akt kinases 1
10(3):318-323
Fidaxomicin lite N-Demethyl Ivabradine Hydrochloride CCG-222740 markedly decreased SRF reporterFidaxomicin is the first in a new class of narrow spectrum macrocyclic antibiotic drugs. It is a fermentation product obtained from the actinomycete Dactylosporangium aurantiacum subspecies hamdenesis. Fidaxomicin is non systemic, meaning it is minimally absorbed into the bloodstream, it is bactericidal, and it has demonstrated selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that